Millipore Sigma Vibrant Logo

580559 Paclitaxel, 6α-Hydroxy- - CAS 153212-75-0 - Calbiochem

View Products on Sigmaaldrich.com
580559
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      CAS #Empirical Formula
      153212-75-0C₄₇H₅₁NO₁₅
      Description
      OverviewA metabolite of the anticancer agent Paclitaxel (Cat. No. 580555).
      Note: 20 nmol = 17.4 µg.
      Catalogue Number580559
      Brand Family Calbiochem®
      Synonyms6-Hydroxytaxol
      References
      ReferencesBaldwin, S.J., et al. 1999. Br. J. Clin. Pharmacol. 48, 424.
      Fischer, V., et al. 1999. Drug Metab. Dispos. 27, 410.
      Product Information
      CAS number153212-75-0
      ATP CompetitiveN
      FormColorless solid
      Hill FormulaC₄₇H₅₁NO₁₅
      Chemical formulaC₄₇H₅₁NO₁₅
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetA metabolite of the anticancer agent Paclitaxel
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 37/38-41-46-60

      Irritating to respiratory system and skin.
      Risk of serious damage to eyes.
      May cause heritable genetic damage.
      May impair fertility.
      S PhraseS: 45-22-26-36/37/39

      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Do not breathe dust.
      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing, gloves and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Carcinogenic / Teratogenic
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsUnstable in solution; reconstitute just prior to use.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      580559 0

      Documentation

      Paclitaxel, 6α-Hydroxy- - CAS 153212-75-0 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Paclitaxel, 6α-Hydroxy- - CAS 153212-75-0 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      580559

      Références bibliographiques

      Aperçu de la référence bibliographique
      Baldwin, S.J., et al. 1999. Br. J. Clin. Pharmacol. 48, 424.
      Fischer, V., et al. 1999. Drug Metab. Dispos. 27, 410.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-September-2008 RFH
      Synonyms6-Hydroxytaxol
      DescriptionA metabolite of the anticancer agent Paclitaxel (Cat. No. 580555). Note: 20 nmol = 17.4 µg.
      FormColorless solid
      CAS number153212-75-0
      Chemical formulaC₄₇H₅₁NO₁₅
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsUnstable in solution; reconstitute just prior to use.
      Toxicity Carcinogenic / Teratogenic
      ReferencesBaldwin, S.J., et al. 1999. Br. J. Clin. Pharmacol. 48, 424.
      Fischer, V., et al. 1999. Drug Metab. Dispos. 27, 410.